Related Experiment Video
Updated: Apr 28, 2026

06:26
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
3.0K
Novel vaccination strategies against tuberculosis
Peter Andersen1, Stefan H E Kaufmann2
1Statens Serum Institut, DK-2300 Copenhagen S, Denmark.
Cold Spring Harbor Perspectives in Medicine
|June 4, 2014
Summary
New tuberculosis (TB) vaccines are critical to combat the ongoing pandemic and drug-resistant strains. Research focuses on novel vaccines and boosters to overcome challenges, especially for latent TB infections.
Area of Science:
- Immunology
- Vaccinology
- Infectious Diseases
Background:
- The global tuberculosis (TB) pandemic persists despite the Bacillus Calmette-Guérin (BCG) vaccine.
- Multidrug-resistant TB poses a significant and growing threat, necessitating improved control strategies.
Purpose of the Study:
- To review the current landscape of TB vaccine research and development.
- To discuss the immunological principles guiding TB vaccine design.
- To outline the essential requirements for an effective TB vaccine.
Main Methods:
- Review of recent scientific literature on TB vaccine candidates.
- Analysis of ongoing clinical trials for novel TB vaccines.
- Discussion of immunological correlates of protection against TB.
Main Results:
- Significant progress in TB vaccine development with numerous preclinical and clinical candidates.
- Vaccine strategies include BCG boosters and BCG replacement vaccines.
- Developing vaccines effective against latent TB infection remains a key challenge.
Conclusions:
- Novel vaccination strategies are urgently required to control TB transmission and combat drug resistance.
- Understanding TB immunology is crucial for designing effective vaccines.
- Future TB vaccines must address the challenge of latent infection for global impact.
Related Concept Videos
Pulmonary Tuberculosis V
984
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
984
Pulmonary Tuberculosis IV
810
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
810
Vaccinations
44.0K
Overview
44.0K
Pulmonary Tuberculosis III
1.7K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.7K
Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Pulmonary Tuberculosis I
1.7K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K

